BeOne Medicines (ONC) Long-Term Debt Issuances (2016 - 2025)
BeOne Medicines (ONC) reported Long-Term Debt Issuances of -$34.4 million for Q4 2025, down 103.89% on a QoQ basis from $885.0 million in Q3 2025.
BeOne Medicines (ONC) has 10 years of Long-Term Debt Issuances data on file, last reported at -$34.4 million in Q4 2025.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$34.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $850.6 million (changed N/A YoY) and the FY2025 annual result came in at $850.6 million, changed N/A from the prior year.
- Long-Term Debt Issuances retreated to -$34.4 million in Q4 2025 per ONC's latest filing, from $885.0 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $885.0 million in Q3 2025 and bottomed at -$34.4 million in Q4 2025.
- The 5-year median for Long-Term Debt Issuances is $6.7 million (2023), against an average of $82.3 million.
- The widest annual swing landed in 2024, when Long-Term Debt Issuances tumbled 234.5%; it then surged 9875.76% in 2025.
- Tracing ONC's Long-Term Debt Issuances over 5 years: stood at $6.0 million in 2021, then surged by 520.9% to $37.4 million in 2022, then tumbled by 160.21% to -$22.5 million in 2023, then jumped by 59.77% to -$9.1 million in 2024, then sank by 280.14% to -$34.4 million in 2025.
- Per Business Quant, the three latest ONC Long-Term Debt Issuances figures stand at -$34.4 million (Q4 2025), $885.0 million (Q3 2025), and -$9.1 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.41 Mn |
| Dec 31, 2025 | -34.41 Mn |
| Sep 30, 2025 | 885.00 Mn |
| Sep 30, 2025 | 885.00 Mn |
| Sep 30, 2024 | -9.05 Mn |
| Sep 30, 2024 | -9.05 Mn |
| Mar 31, 2024 | 9.05 Mn |
| Mar 31, 2024 | 9.05 Mn |
| Dec 31, 2023 | -22.50 Mn |
| Dec 31, 2023 | -22.50 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 15.77 Mn |
| Jun 30, 2023 | 15.77 Mn |
| Sep 30, 2022 | 37.37 Mn |
| Sep 30, 2022 | 37.37 Mn |
| Sep 30, 2021 | 6.02 Mn |
| Sep 30, 2021 | 6.02 Mn |
| Jun 30, 2021 | 155,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | 10.66 Mn |
| Mar 31, 2021 | 10.66 Mn |
| Dec 31, 2020 | 45.92 Mn |
| Dec 31, 2020 | 45.92 Mn |
| Sep 30, 2020 | 14.76 Mn |
| Sep 30, 2020 | 14.76 Mn |
| Jun 30, 2020 | 49.53 Mn |
| Jun 30, 2020 | 49.53 Mn |
| Sep 30, 2019 | 23.79 Mn |
| Sep 30, 2019 | 23.79 Mn |
| Jun 30, 2019 | 7.01 Mn |
| Jun 30, 2019 | 7.01 Mn |
| Mar 31, 2019 | 36.70 Mn |
| Mar 31, 2019 | 36.70 Mn |
| Jun 30, 2018 | 42.32 Mn |
| Jun 30, 2018 | 42.32 Mn |
| Dec 31, 2017 | 132.76 Mn |
| Dec 31, 2017 | 132.76 Mn |
| Sep 30, 2017 | -132.76 Mn |
| Sep 30, 2017 | -132.76 Mn |
| Dec 31, 2016 | -113,000.00 |
| Dec 31, 2016 | -113,000.00 |